Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab.

Pancholy, Maitri; Storey, Philip P; Wood, Edward H; Chaudhary, Varun; Obeid, Anthony; Marlow, Elizabeth; Farley, Nathan D; Wolfe, Jeremy D; Garg, Sunir J

Pancholy, Maitri; Storey, Philip P; Wood, Edward H; Chaudhary, Varun; Obeid, Anthony; Marlow, Elizabeth; Farley, Nathan D; Wolfe, Jeremy D; Garg, Sunir J.

Afiliación

Pancholy M; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Storey PP; Department of Ophthalmology, Emory University, Atlanta, GA, USA.
Wood EH; Austin Retina Associates, University of Texas Dell Medical School, Austin, TX, USA.
Chaudhary V; Department of Ophthalmology, Stanford University, Stanford, CA, USA.
Obeid A; McMaster University, Hamilton, ON, Canada.
Marlow E; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Farley ND; Bay Area Retina Associates, Oakland, CA, USA.
Wolfe JD; Associated Retinal Consultants, Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA.
Garg SJ; Associated Retinal Consultants, Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA.

J Vitreoretin Dis ; 6(5): 358-366, 2022.

Article en En | MEDLINE | ID: mdl-37006897

Palabras clave

anti-VEGF; dexamethasone; endophthalmitis; ranibizumab; retina

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: J Vitreoretin Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google